Question · asked by 1 review
IVIg vs placebo: Adverse events
- Population
- adults with renal vasculitis
- Intervention
- IVIg
- Comparison
- placebo
- Outcome
- Adverse events
Intravenous immunoglobulin may leads to higher adverse events compared with placebo (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intravenous immunoglobulin vs placebo Adverse events · adults with renal vasculitis Intravenous immunoglobulin may leads to higher adverse events compared with placebo (low certainty). Interventions for renal vasculitis in adults (2020) · Cochrane Headline outcomes only | RR 3 | 1 study · 34 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for renal vasculitis in adults 2020 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- IVIg vs placebo · people with postpolio syndrome · 1 review
- IVIg vs SCIg · people with multifocal motor neuropathy · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.